tiprankstipranks
Trending News
More News >
Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
US Market

Valeo Pharma (VPHIF) Income Statement

Compare
14 Followers

Valeo Pharma Income Statement

Last quarter (Q3 2024), Valeo Pharma's total revenue was C$12.60M, a decrease of -10.52% from the same quarter last year. In Q3, Valeo Pharma's net income was C$-8.19M. See Valeo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 53.91MC$ 27.75MC$ 13.56MC$ 7.47MC$ 6.58M
Gross Profit
C$ 13.08MC$ 6.28MC$ 3.96MC$ 1.38MC$ 1.40M
Operating Expenses
C$ 30.30MC$ 28.12MC$ 16.65MC$ 5.72MC$ 5.14M
Depreciation and Amortization
C$ 2.63MC$ 1.05MC$ 407.00KC$ 424.00KC$ 135.00K
EBITDA
C$ -11.39MC$ -16.10MC$ -10.97MC$ -3.74MC$ -3.41M
Operating Income
C$ -17.23MC$ -19.60MC$ -12.82MC$ -4.34MC$ -3.54M
Other Income/Expenses
C$ -10.58MC$ -7.32MC$ -1.42MC$ -418.00KC$ 122.00K
Pretax Income
C$ -27.81MC$ -26.92MC$ -14.23MC$ -4.76MC$ -3.62M
Net Income
C$ -27.81MC$ -25.75MC$ -14.23MC$ -4.76MC$ -3.62M
Per Share Metrics
Basic EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Diluted EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Weighted Average Shares Outstanding
86.12M 80.86M 69.93M 57.91M 49.59M
Weighted Average Shares Outstanding (Diluted)
86.12M 80.86M 69.93M 57.91M 49.59M
Currency in CAD

Valeo Pharma Earnings and Revenue History